Women are almost twice as likely as men to be diagnosed with anxiety. Depression, PTSD, perinatal mental health conditions and...
John Legend, Chrissy Teigen, Pedro Pascal and Zac Efron are among the celebrities who have individually invested in the company
By Dr Anne Welsh, clinical psychologist, executive coach and consultant
Unlike previous generations, women in France are now more willing to speak up and take their health into their own hands
The move marks the first time the FDA has formally forced the removal of a drug
The London-based company aims to help combat late-stage cancers using proprietary technology
Around 300 women in England with HER2-negative early breast cancer will be eligible for the new drug each year
By Lorin Gu, founding partner at Recharge Capital
The new period shorts will debut on the pitch during the Women's World Cup 2023
The at-home technology aims to address key women's health areas, including fertility, contraception and endocrine conditions
By Inessa Lurye, senior director of product and head of women’s health programme at Hinge Health
Clue has extended an invite to its user community to become investors via Crowdcube
Mental health start-up Wysa calls for more support for female employees
Elvie is one of the first beneficiaries of HSBC UK’s new £250m growth lending proposition
Research reveals a complex and overlapping system that contributes to inequalities in treatment experience
The treatment could "transform" the life of women suffering from menopause symptoms globally, say experts
The singer wants to champion the brand's mission to create an open dialogue around sexual wellness
Findings could open up avenues for designing new medical treatments targeting subtypes of endometriosis, say scientists
The system would provide clinicians with a suite of AI tools and applications to advance the diagnostic experience
The offering will expand access to HRT for women in every major region worldwide
The pharma industry funnels only two per cent of annual revenue from contraceptives back into research and development
